4 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 2 | Unknown 2 |
Follow Hormone Refractory Prostate Cancer: new trials by email Literature Review of Hormone Refractory Prostate Cancer trials Research Report on Hormone Refractory Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients SHR3680 - Hormone Refractory Prostate Cancer, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 197 | 2016-04-12 | 2020-05-13 |
| Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer Docetaxel * Sunitinib, Docetaxel - Hormone Refractory Prostate Cancer | Phase 2 | Unknown | Medical University of Vienna | 60 | 2008-11-01 | 2010-08-18 |
| Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients Fermented Wheat germ extract - Hormone Refractory Prostate Cancer | Phase 2 | Unknown | Sheba Medical Center | 60 | 2007-06-01 | 2009-07-31 |
| A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer Picoplatin, docetaxel - Hormone Refractory Prostate Cancer | Phase 1 / Phase 2 | Unknown | Poniard Pharmaceuticals | 95 | 2006-06-01 | 2009-01-21 |
Prostatic Neoplasms (2) · Neoplasm Metastasis (1) · Neoplasms (1)
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Docetaxel (2) · Avemar (1) · Sunitinib (1) · amminedichloro(2-methylpyridine)platinum(II) (1)
Jiangsu HengRui Medicine Co., Ltd. (1) · Medical University of Vienna (1) · Poniard Pharmaceuticals (1) · Sheba Medical Center (1)
Austria (1) · China (1) · Israel (1) · Russia (1)
Dingwei Ye, M.D. (1) · Michael MK Krainer, MD (1) · Robert Earhart, MD (1) · Rony Weitzen, MD (1)